Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126113331 | 12611333 | 1 | I | 2007 | 20160502 | 20160801 | 20160801 | EXP | US-DSJP-DSU-2016-115258 | DAIICHI | 0.00 | Y | 0.00000 | 20160801 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126113331 | 12611333 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | UNK | Y | 21286 | TABLET | |||||||||
| 126113331 | 12611333 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 5 MG, QD | Y | 21286 | 5 | MG | TABLET | QD | |||||
| 126113331 | 12611333 | 3 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, UNK | Y | 21286 | 20 | MG | TABLET | |||||||
| 126113331 | 12611333 | 4 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, UNK | Y | 21286 | 40 | MG | TABLET | |||||||
| 126113331 | 12611333 | 5 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | U | 0 | FILM-COATED TABLET | |||||||||
| 126113331 | 12611333 | 6 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | Nasal | 2 PUFFS, AS NEEDED, QID | 0 | 90 | UG | INHALER | QID | ||||||
| 126113331 | 12611333 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, QD | 0 | 500 | MG | TABLET | QD | |||||||
| 126113331 | 12611333 | 8 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | 10 MG, AS NEEDED | 0 | 10 | MG | |||||||||
| 126113331 | 12611333 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, QD | 0 | 81 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126113331 | 12611333 | 1 | Hypertension |
| 126113331 | 12611333 | 5 | Hypertension |
| 126113331 | 12611333 | 6 | Product used for unknown indication |
| 126113331 | 12611333 | 7 | Glucose tolerance impaired |
| 126113331 | 12611333 | 8 | Product used for unknown indication |
| 126113331 | 12611333 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126113331 | 12611333 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126113331 | 12611333 | Anorectal swelling | |
| 126113331 | 12611333 | Cholecystitis chronic | |
| 126113331 | 12611333 | Diverticulum | |
| 126113331 | 12611333 | Haemorrhoids | |
| 126113331 | 12611333 | Hiatus hernia | |
| 126113331 | 12611333 | Malabsorption | |
| 126113331 | 12611333 | Polyp |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126113331 | 12611333 | 1 | 2006 | 0 | ||
| 126113331 | 12611333 | 2 | 2009 | 201508 | 0 | |
| 126113331 | 12611333 | 3 | 2009 | 201508 | 0 | |
| 126113331 | 12611333 | 4 | 2009 | 201508 | 0 | |
| 126113331 | 12611333 | 5 | 2009 | 201508 | 0 |